![Benjamin Maynor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Maynor
Corporate Officer/Principal bij
American Chemical Society
Profiel
Benjamin Maynor is a member of the American Chemical Society and the American Association of Pharmaceutical Scientists.
He was previously the Senior Vice President-Research & Development at Liquidia Technologies, Inc. from 2015 to 2020, an Associate at The University of North Carolina at Chapel Hill in 2004-2005, a Scientist at Polestar Technologies, Inc. from 1996 to 1999, and the Vice President-Research at Envisia Therapeutics, Inc. from 2013 to 2015.
He holds a doctorate from Duke University and an undergraduate degree from Harvard University.
Currently, Dr. Maynor holds positions at the American Chemical Society and the American Association of Pharmaceutical Scientists.
Actieve functies van Benjamin Maynor
| Bedrijven | Functie | Begin |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Corporate Officer/Principal | - |
Eerdere bekende functies van Benjamin Maynor
| Bedrijven | Functie | Einde |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ocular therapies | Corporate Officer/Principal | 01-03-2015 |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-09-2005 |
Polestar Technologies, Inc.
 Polestar Technologies, Inc. Industrial MachineryProducer Manufacturing Provides optical monitoring, sensing, and probes | Corporate Officer/Principal | 01-06-1999 |
Opleiding van Benjamin Maynor
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
89
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Health Technology |
Polestar Technologies, Inc.
Polestar Technologies, Inc. Industrial MachineryProducer Manufacturing Provides optical monitoring, sensing, and probes | Producer Manufacturing |
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel ocular therapies | Health Technology |
Kies MarketScreener 
